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CO-PRODUCTION OF KNOWLEDGE
International experiences with co-production and 
people centredness offer lessons for covid-19 
responses
Eva Turk and colleagues believe that there is much to learn from the experiences of low and 
middle income countries in co-producing knowledge and working with communities to find feasible 
and acceptable solutions to healthcare concerns
The development and imple-mentation of health policies and interventions must be done with, and not simply done to, the people affected. Collaborative 
healthcare requires engaging with individu-
als and communities using models of care 
that are patient centred. These models are 
informed, rather than dictated, by scientific 
knowledge that might or might not apply 
to an individual patient and their circum-
stances.1 Collaboration allows patients, 
user groups, and communities to assert 
some control over delivery of their care and 
hold health providers to account. Given the 
uncertainty and mistrust about how best to 
deal with the covid-19 pandemic, collabora-
tion is more important than ever.
Co-production of healthcare can take 
place throughout the health system, 
ranging from governments working with 
patient organisations, to health facilities 
involving patient representatives, to 
the clinical meeting between a health 
professional and a patient.2 Put simply, 
it involves “getting everybody around 
the table so you are valuing everyone’s 
knowledge.”3 It demands building a shared 
understanding between researchers, policy 
makers, practitioners, and managers, as 
well as patients and their families, and 
working together to improve quality and 
care.
While there should be little disagreement 
that co-production is a good idea, it does 
need a supportive culture and regulatory 
framework, with organisational structures 
and procedures in place.4 5 It also requires 
acceptance of the need to share power, 
take account of each other’s perspectives 
and skills, respect and value different types 
of knowledge, and commit to building and 
maintaining the relationships within the 
collaboration process. Co-production is 
therefore a dynamic and often complex 
process in which information, resources, 
timescales, and people are continually 
changing.6 7
Co-production is increasingly used 
within health research, building on 
methods such as participatory research, 
engaged scholarship, collaborative 
research, and integrated knowledge 
translation.8 9 We see it as occurring where 
researchers work in partnership with 
knowledge users, comprising patients 
and care givers, clinicians, policy makers, 
health system leaders, the public, and 
others, to identify a problem and produce a 
solution, sharing power and responsibility 
throughout the research.10 Consequently, 
co-production in health research overlaps 
with its application in healthcare provision. 
Both focus on improving quality, whether of 
health research, policies, or interventions, 
in order to increase acceptance and uptake 
of healthcare by end users.
Co-production places patients at the centre
The involvement of communities in the co-
production of research and the provision 
of health services can improve health and 
wellbeing and make policy initiatives more 
sustainable.11-13 By embedding principles of 
equity, dignity, respect, and trust in com-
munication among different stakehold-
ers, co-production can also enhance the 
accountability and person centredness of 
health systems.14
Application of these principles to the 
design of people centred health systems 
can take different forms. Coulter and 
colleagues, in the “house of care,” seek to 
co-produce health based on a conversation 
between clinicians and patients.15 Wagner’s 
chronic care model and the World Health 
Organization framework on integrated, 
people centred health services also 
emphasise the importance of patients 
working with health professionals to 
improve functional and clinical outcomes. 
Such processes must also be supported 
by appropriate resources and policies.16 17 
Others describe a co-produced healthcare 
service in which patients and professionals 
interact as participants within health 
systems.18
Our experiences in low and middle 
income countries show how co-production 
challenges the traditional roles of health 
professionals and researchers, which are 
often based on long established imbalances 
of power. Co-production is not always easy, 
but to achieve community participation 
in health research and practice, we must 
overcome barriers created by existing 
hierarchies.19
In Peru, researchers, health workers, 
and policy makers,  working with 
communities, co-produced interventions 
to improve diagnosis and management 
of chronic diseases in rural areas as 
part of the COmmunity HEalth System 
InnovatiON (COHESION) project.20 21 
They developed a package that included 
radio programmes to help improve health 
literacy among patients, and interventions, 
such as training for health workers and 
KEY MESSAGES
•   For too long, health research and the 
development of health policies and 
interventions have been done to, and 
not with, communities and individu-
als, often leading to failure
•   The covid-19 pandemic has shown 
the importance of strengthening the 
co-production of health research and 
provision of health services by embed-
ding a people centred approach at all 
levels of healthcare in all countries
•   To build back better, researchers and 
policy makers need to rethink how to 
involve communities in co-production 
of research, knowledge, and health 
systems
•   Power dynamics between different 
groups create barriers that must be 
dealt with if progress is to be made
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infrastructure improvements. Because 
the local measures were embedded within 
a national framework, they worked at all 
levels of the health system, supported by 
a national advisory group. Patients and 
healthcare providers were each provided 
with a safe space to identify and discuss 
their own concerns and priorities. The 
groups then joined together to find 
shared solutions, which included jointly 
selecting and prioritising interventions. 
The collaboration process supported 
patients and health providers in finding 
sustainable and acceptable solutions to 
improve the diagnosis and management 
of chronic diseases. The process did have 
its challenges, however, such as managing 
the expectations and requirements of 
the community while following best 
scientific practice. To develop the package, 
the different stakeholders also had to 
interact regularly, which occupied more 
of people’s time and resources than other 
approaches.20
Co-production requires transparency 
and accountability to achieve the mutual 
trust that is sometimes lacking within 
health systems.22 Consultation with 
health service users requires methods 
that are more than just a token. If service 
users are to have a measurable effect on 
social, health, and service outcomes, there 
must be a real sharing of power.23 24 For 
example, the Nigeria Centre for Disease 
Control established a covid-19 research 
consortium to strengthen the involvement 
of stakeholders in the co-production of 
research. Researchers, policy makers, 
and representatives of those on the front 
line of the covid-19 response collaborated 
to define national research priorities, 
map existing resources, and develop and 
implement a long term programme for 
research—the Nigeria covid-19 research 
plan, 2020-4.25
In Tanzania, health facility governing 
committees have been established in 
district hospitals, health centres, and 
dispensaries to increase transparency 
and accountability for the planning and 
provision of healthcare. These committees 
offer a way for communities and patients 
to be involved in decision making so that 
health services become more responsive to 
their needs.26 Facilities have developed new 
ways of including the most marginalised 
groups—for example, by providing 
appropriate face to face health education 
for community members with low levels 
of literacy. Although the committees 
have created a sense of ownership 
and acceptance of decisions within 
communities, their future faces resource 
constraints, including low educational 
levels among committee members and 
inadequate funds.27
Strengthening inclusivity in the co-production 
of knowledge
We should not minimise the substan-
tial challenges to adopting a co-produc-
tion approach or the shift in thinking it 
requires.28 Although the co-production of 
health research is increasing, it has a long 
way to go. A systematic review of com-
munity participation in health systems 
research identified 260 papers with more 
than nominal community participation in 
the research described. In 95% of papers, 
communities helped in implementing an 
intervention but were involved in identify-
ing and defining problems in only 18% of 
articles.29 Only five papers discussed power 
imbalances. Overall, the literature showed 
little recognition of the many problems that 
can influence a community’s participation 
in the co-production of research and mod-
els of care, including power relations, pre-
vailing knowledge, and beliefs and cultural 
barriers.
Those responsible for planning, 
developing, and implementing acceptable 
health services must adopt an inclusive 
approach to the construction of knowledge. 
This approach requires a move away 
from the dominant supply driven modes 
of knowledge, “push,” to an approach 
that emphasises demand, “pull,” where 
services are effectively tailored and 
targeted. Such an approach, however, can 
place competing pressures on the time 
and capacity of patients and providers to 
participate, and highlights the need for 
appropriate structures.30-32
Failure to co-produce knowledge also 
has a cost. For example, the Nigerian 
government developed a national 
risk communication campaign, ‘Take 
Responsibility’, to increase covid-19 
awareness within the population.33 It soon 
became clear, however, that the initial 
messaging, developed by officials and 
disseminated in a top down fashion, was 
not appropriate because it did not deal 
with differences such as literacy, language, 
and other sociocultural variations. This 
messaging was replaced by a process of 
community engagement to understand 
people’s fears and beliefs and which 
supported communities to work with 
risk communication officers and trained 
state health educators to co-develop their 
own risk communication messages and 
dissemination strategies. Focus group 
discussions and audio diagnosis (providing 
feedback and ensuring understanding of 
audiovisual communication materials) 
were used to develop and assess jingles, 
role play, animations, infographics, and 
messages to be conveyed by town criers. 
Images depicted key health promotion 
messages, such as people standing with 
horizontally outstretched arms to convey 
two metres distance, and content was 
translated into local languages. Polling 
results showed that within 12 weeks of 
implementing these new strategies in 
Lagos, an increase of 22% occurred (from 
59% to 81%) in the proportion of the 
population that considered covid-19 to be 
real and not a hoax.34
I f  co -production is  to  be  truly 
transformative, there must be a shift of 
power towards patients and communities. 
New types of relationship must be 
developed between patients, health 
professionals, and researchers, supported 
by political commitment.35 We know such 
transformation is not easy so it is perhaps 
unsurprising that a recent systematic 
review of primary care interventions 
for non-communicable disease found 
that even when the terminology of 
co-production is used there is little 
connection between local community 
priorities and interventions implemented.36 
The Ebola outbreak in west and central 
Africa exemplified the misunderstandings 
and distrust that can arise when priorities 
and solutions are imposed on local 
communities.37 Social scientists identified 
many situations where researchers and 
policy advisers understood the situation 
differently from the local populations.38 
When researchers did engage effectively 
with patients and frontline health workers 
in the development of health services 
and conduct of research, popular fears 
about treatment centres were allayed and 
public trust grew. The anthropologist Paul 
Richards has written a detailed account of 
how researchers and local communities 
worked together to find solutions that 
were both practical and acceptable as 
they gained what he called “merged 
understanding.” 37 39
Similarly, during the covid-19 pandemic, 
governments and health authorities in 
many countries have repeatedly imposed 
top down measures, which, while informed 
by research, often took little account of the 
communities affected.40 Developing covid-
19 measures that are feasible and practical 
is crucial, as is understanding what 
communities value and need in times of 
crisis. Such measures will not be achieved 
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unless communities are encouraged and 
enabled to become active partners in 
research and the provision of healthcare. 
It requires the support of governments and 
imaginative solutions by all stakeholders. 
The Social Science in Humanitarian Action 
Platform shows why it is important for 
patients and communities to be at the 
centre of co-production approaches during 
emergency responses.41
Looking forward
Covid-19 offers an exceptional opportunity 
to strengthen the co-production of health 
research and provision of health services by 
embedding a people centred approach in all 
levels of healthcare. Solutions to health prob-
lems can be found when patients with lived 
experiences, their families, and communi-
ties come together with researchers, health 
professionals, and decision makers to co-pro-
duce knowledge. A co-production approach 
would make it possible to build back better 
after the pandemic with more resilient health 
systems that focus on what people need.
Partnerships between researchers, 
practitioners, and policy makers in health 
research and practice are morally right 
and, at least when adequately supported, 
can work. However, co-production can 
place additional burdens, both financial 
and temporal, on those involved, and 
might not always be feasible. Even when 
structures are put in place to support 
co-production and promote person 
centredness and accountability, power 
imbalances can remain. Overcoming 
barriers to engagement by all requires 
understanding the dynamics of intergroup 
relationships, and recognising, and 
dealing with, the inequitable distribution 
of social, economic, and political 
resources among stakeholders within the 
co-production process.42 Only then can 
there be a shift of power towards patients 
and communities which allows for the 
identification of community priorities and 
the co-production of relevant research and 
healthcare in response to their needs.
We need more research on the critical 
factors that enable co-production to deliver 
effective, accountable, and people centred 
health services.19 We also require a better 
understanding of the often opaque power 
imbalances and competing incentives, 
including nepotism and corruption, that 
characterise some decision making in 
health.43
Co-production in health research and 
practice offers a means to shift from “sick 
care,” and a focus on disease, to “people 
centred care,” and a focus on people. 
Putting patients at the centre of their care, 
is not a panacea and will not always lead to 
perfect processes, but it is surely a necessary 
and welcome step towards more equitable, 
accountable, and resilient health systems.
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